Skip to main content

Table 4 Traditional risk factors and outcomes

From: Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements

Demographics

n = 37a

%

pEFS

P = 

Age group

 Infant group

12

 

50.00 ± 14.43%

0.9974

 Noninfant group

25

 

35.35 ± 11.28%

 

Gender

 Male

23

 

57.80 ± 12.00%

0.0160

 Female

14

 

15.71 ± 10.18%

 

WBC count

  ≥ 50 × 109/L

25

 

30.03 ± 10.44%

0.1178

  < 50 × 109/L

12

 

67.50 ± 15.51%

 

  ≥ 300 × 109/L

6

 

16.67 ± 14.83%

0.0342

  < 300 × 109/L

31

 

49.57 ± 10.38%

 

LDH (U/L)

  ≥ 2 N

24

 

32.23 ± 15.06%

0.1762

  < 2 N

13

 

45.36 ± 11.07%

 

CNSL involvement

 CNSL-

35

 

41.95 ± 9.34%

-

 CNSL + 

2

 

-

 

KMT2Ar subtype

 KMT2A-AFF1

16

 

30.00 ± 11.78%

0.1745

 Non KMT2A-AFF1

21

 

51.83 ± 12.88%

 

 KMT2A-AFF1

16

 

30.00 ± 11.78%

0.4154

 KMT2A-MLLT3

11

 

50.00 ± 15.81%

 
  1. a patients without TRM